GlassScriptPhysician profile
Katlin Nolan Hancock
NPI 1497200638
$5,451.54
in general payments reported to CMS, 2019-2025
48 companies · $1,293 in 2025
The $1,293 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $523 · 2023: $690 · 2024: $2,845 · 2025: $1,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,517 · Travel and Lodging: $1,145 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,517.48 |
| Travel and Lodging | $1,144.98 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,663.09 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $637.08 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $521.62 | 2022-2025 | |
| Janssen Biotech, INC. | $201.63 | 2022-2024 | Erleada, Akeega, Stelara |
| Astellas Pharma US INC | $176.85 | 2021-2024 | |
| Valencia Technologies Corporation | $157.94 | 2025 | Ecoin Device Kit |
| Boston Scientific Corporation | $130.12 | 2023-2025 | Axonics, Spaceoar Vue System - 10ml |
| Pfizer INC. | $120.96 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $115.67 | 2021-2025 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $113.24 | 2021-2024 | |
| Antares Pharma, INC. | $84.88 | 2024 | Xyosted |
| Abc Home Medical Supply, INC. | $80.76 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $80.17 | 2024 | Adstiladrin |
| Celgene Corporation | $76.46 | 2022-2023 | Zeposia |
| Endo USA, INC. | $70.38 | 2024-2025 | Xiaflex |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katlin Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.